Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for AMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
June 30, 2026 180.75M
March 31, 2026 196.35M
December 31, 2025 211.49M
September 30, 2025 200.92M
June 30, 2025 205.20M
March 31, 2025 181.99M
December 31, 2024 199.17M
September 30, 2024 219.24M
June 30, 2024 247.98M
March 31, 2024 244.08M
December 31, 2023 279.59M
September 30, 2023 285.88M
June 30, 2023 290.89M
March 31, 2023 275.40M
December 31, 2022 290.85M
September 30, 2022 320.48M
June 30, 2022 393.19M
March 31, 2022 332.60M
December 31, 2021 400.97M
September 30, 2021 393.31M
June 30, 2021 399.67M
March 31, 2021 355.64M
December 31, 2020 338.52M
September 30, 2020 352.95M
June 30, 2020 312.11M
Date Value
March 31, 2020 339.89M
December 31, 2019 273.95M
September 30, 2019 271.04M
June 30, 2019 240.84M
March 31, 2019 231.37M
December 31, 2018 233.38M
September 30, 2018 263.11M
June 30, 2018 250.82M
March 31, 2018 232.37M
December 31, 2017 228.44M
September 30, 2017 212.72M
June 30, 2017 208.83M
March 31, 2017 204.17M
December 31, 2016 178.98M
September 30, 2016 178.88M
June 30, 2016 312.05M
March 31, 2016 308.85M
December 31, 2015 302.65M
September 30, 2015 293.51M
June 30, 2015 286.52M
March 31, 2015 277.16M
December 31, 2014 259.56M
September 30, 2014 248.44M
June 30, 2014 255.82M
March 31, 2014 277.80M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Neurocrine Biosciences, Inc. 1.666B
Cellectis SA 226.30M
Alkermes Plc 2.585B
Akari Therapeutics Plc 20.03M
Liquidia Corp. 326.80M

Total Liabilities (Quarterly) Related Metrics